Patients’ decisions on whether to receive treatment for actinic keratosis (AK) is significantly affected by physician wording, especially with alterations in the presentation of risk of malignant transformation, a recent study found. A prospective survey study was performed from June 1 to July 31, 2016, in participants who were recruited through the Penn State Milton S. Hershey Dermatology Clinic and an online survey site. A total of 571 individuals were recruited; 539 (94.4%) returned completed surveys. The mean (SD) age of respondents was 42.9 (17.8) years; 306 (56.8%) were women. Researchers found:
- The decision to receive treatment for AK varied from 57.7% (n=311) to 92.2% (n=497) for the 5 scenarios presented in the questions.
- The question that presented AK as a “precancer” had the highest proportion of participants who preferred treatment (497 [92.2%]).
- 2 questions that presented the risk of AK as not progressing to cancer had the lowest proportion of individuals who chose treatment (311 [57.7%] and 328 [60.9%]).
Berry K, Butt M, Kirby JS. Influence of information framing on patient decisions to treat actinic keratosis. [Published online ahead of print January 18, 2017]. JAMA Dermatol. doi:10.1001/jamadermatol.2016.5245.
This Week's Must Reads
Racial/Ethnic Differences in Childhood Eczema Care, J Am Acad Dermatol; 2017 Dec; Fischer, et al
Eczema Herpeticum Hospitalizations Increase Noted, J Invest Dermatol; ePub 2017 Sep 16; Hsu, Shinkai, et al
Atopic Dermatitis Linked with Hand Eczema, Br J Dermatol; ePub 2017 Nov 24; Ruff, et al
EAPs Aid Patients with Limited Health Literacy , J Cutan Med Surg; ePub 2017 Nov 3; McEvoy, et al
Phenotypical Differences of Adult, Childhood AD, J Allergy Clin Immunol; ePub 2017 Nov 10; Silverberg, et al
Must Reads in Actinic Keratosis
Cost of Managing AK Varies by Region, JAMA Dermatol; ePub 2017 Mar 1; Kirby, et al
Physician Wording Role in Seeking AK Treatment, JAMA Dermatol; ePub 2017 Jan 18; Berry, Butt, et al
Acantholysis in SCC Not Considered High Risk, J Am Acad Dermatol; ePub 2016 Nov 23; Ogawa, et al
Prevalence of Nonmelanoma Skin Cancers High in VHA, Dermatol Surg; ePub 2016 Jul 25; Yoon, Phibbs, et al
FDA Approves Ameluz for Actinic Keratosis, Biofrontera news release; 2016 May 11